Larvol Delta - Chase-Therapeutics-Announces-20-Million-Series-B-Financing-to-Advance-Clinical-Trials-in-Parkinsons-Disease-and-Major-Depressive-Disorder

pramipexole ER (CTC-413) - Chase Therap

pramipexole immediate release (CTC-501) - Chase Therap

https://www.businesswire.com/news/home/20211020005345/en/Chase-Therapeutics-Announces-20-Million-Series-B-Financing-to-Advance-Clinical-Trials-in-Parkinson%E2%80%99s-Disease-and-Major-Depressive-Disorder

Oct 20, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next